Skip to content

A Pilot Research Project on Outcome of Trauma Informed Stabilization Treatment (TIST) for Adults with Complex Trauma Symptoms After Childhood Trauma, At the Department of Trauma Treatment, Modum Bad, Norway

Residential Group and Individual Trauma Informed Stabilization Therapy for Adult Survivors of Childhood Trauma

Status
Enrolling by invitation
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06719167
Enrollment
32
Registered
2024-12-05
Start date
2024-10-24
Completion date
2026-12-01
Last updated
2024-12-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

PTSD, PTSD and Trauma-related Symptoms

Keywords

complex PTSD, childhood trauma, TIST, group treatment, affect regulation, mindfulness, self compassion

Brief summary

The purpose of the study is to examine the effects of residential group and individual Trauma Informed Stabilization Treatment (TIST) for complex symptoms in adult survivors of childhood trauma in a naturalistic observational study.

Detailed description

Adult survivors of childhood trauma have complex and diverse symptom profiles. The aim of the study is to examine the effects of theTrauma Informed Stabilization Treatment (TIST) model, developed by dr Janina Fisher, in adult survivors of childhood trauma. 32 patients will be recruited from referrals to an residential open door trauma clinic in Norway, Modum Bad. Patients will be admitted for in-patient pre-planned treatment over 11 weeks - consisting of individual therapy and group therapy using different modalities, all within the TIST approach and framework. Patients will be summoned for 6 day follow-up 8 months after treatment.

Interventions

BEHAVIORALPsychoterapy

During 11 weeks admission the programme will include group sessions using different modalities (psychoeducation videos, live psychoeducation groups, expressive arts therapy, equine facilitated therapy, mindfulness and discussion groups) all using TIST methodology. Parallell individual therapy with therapist (psychologist or psychiatrist) and milieu therapist. All therapists will be trained minimum in TIST level 1 and recieve supervision from an expert TIST therapist.

Sponsors

Modum Bad
Lead SponsorOTHER

Study design

Observational model
CASE_ONLY
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Adults ≥18 years * Complex symptom presentations connected to childhood trauma * All patients will have undergone outpatient therapy with insufficient effect * Most included patients will have a diagnosis of complex PTSD (diagnosed by M.I.N.I. and clinical evaluation) * Patients may have diagnosis of unspecified dissociative disorder, personality disorders, depression and other comorbidity.

Exclusion criteria

* Dissociative identitiy disorder * Ongoing psychosis * Ongoing drug addiction * Very disturbed group function * Ongoing life crisis * Mental disability * Acute suicidality * Ongoing severe self harm * Patients with complex dissociative disorders and patients eligible for exposure therapy will be referred to/prioritized for other treatment programmes.

Design outcomes

Primary

MeasureTime frameDescription
Difficulties in emotion regulation scale (DERS)Week 0 (Admission), week 11-12 (discharge) and 8 months follow upDifficulties in emotion regulation scale, scale and subscales
Five facet mindfulness questionnaire (FFMQ)Week 0 (Admission), week 11-12 (discharge) and 8 months follow upFive facet mindfulness questionnaire, all subscales
Self-compassion scale long form (SCS-LF)Week 0 (Admission), week 11-12 (discharge) and 8 months follow upSelf-compassion scale long form, scale and subscales
PTSD checklist for DSM-5 (PCL-5)Week 0 (Admission), week 11-12 (discharge) and 8 months follow upPTSD checklist for DSM-5, scale and subscales
International trauma questionnaire (ITQ)Week 0 (Admission), week 11-12 (discharge) and 8 months follow upInternational trauma questionnaire, scale and subscales

Secondary

MeasureTime frameDescription
Patient health questionnaire 9 (PHQ-9)Week 0 (Admission), week 11-12 (discharge) and 8 months follow upPatient health questionnaire 9
Quality of lifeWeek 0 (Admission), week 11-12 (discharge) and 8 months follow upSelf report on scale of 0-10

Countries

Norway

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026